{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T18:18:06Z","timestamp":1793470686385,"version":"4.5.0"},"reference-count":52,"publisher":"Walter de Gruyter GmbH","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_cclm-2025-0133_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Late-night salivary cortisol (LNSC), which assesses the loss of the circadian rhythm of cortisol, is one of the first-line tests performed to diagnose Cushing\u2019s syndrome (CS). Unfortunately, access to LNSC is still limited in some institutions. Alternatively, midnight serum cortisol can be measured, often combined with additional cortisol sampling over 24\u202fh. This study investigates the performance of afternoon serum cortisol (F16h) for the positive diagnosis of hypercortisolism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_cclm-2025-0133_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective study including consecutive patients evaluated for suspicion of CS by at least two tests among urine-free cortisol (UFC), overnight 1-mg dexamethasone suppression test (DST), and midnight serum cortisol (F00h). Patients assessed for adrenal incidentalomas or Cushing\u2019s disease recurrence were excluded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_cclm-2025-0133_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 589 included patients (41.3\u202f% women, mean age 50.7\u00a0\u00b1 16.3 years), 49 (8.3\u202f%) were diagnosed with CS. F16h demonstrated significant correlations with DST, UFC, and F00h (r=0.24, p&lt;0.001, r=0.41, p&lt;0.001 and r=0.42, p&lt;0.001, respectively). The optimal cut-off of the F16h was 218\u202fnmol\/L, achieving 83.7\u202f% sensitivity, 67.4\u202f% specificity, and a 97.8\u202f% negative predictive value. The area under the ROC curve (AUC) for the F16h did not differ from UFC (0.83 vs. 0.79, p=0.3), yet its sensitivity was higher using the optimal diagnostic threshold. The AUC for the F16h was significantly lower than that for F00h and\u00a0DST.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_cclm-2025-0133_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Given the limited diagnostic accuracy of both F16h and UFC, particularly in mild to moderate CS, efforts should prioritize expanding access to reliable LNSC assays for circadian rhythm assessment. Meanwhile, F16h may help rule out CS when LNSC is unavailable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/cclm-2025-0133","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T12:56:12Z","timestamp":1752152172000},"page":"2254-2263","source":"Crossref","is-referenced-by-count":2,"title":["Performance of afternoon (16:00\u202fh) serum cortisol for the diagnosis of Cushing\u2019s syndrome"],"prefix":"10.1515","volume":"63","author":[{"given":"Hippolyte","family":"Dupuis","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Diabetology and Metabolism, Hospital Huriez , University Hospital of Lille , Lille , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Merlen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Metabolism, Hospital Huriez , University Hospital of Lille , Lille , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Elices-Diez","sequence":"additional","affiliation":[{"name":"INCLUDE\u00a0\u2013\u00a0Integration Center of the Lille University hospital for Data Exploration , Lille University Hospital , Lille , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Balay\u00e9","sequence":"additional","affiliation":[{"name":"INCLUDE\u00a0\u2013\u00a0Integration Center of the Lille University hospital for Data Exploration , Lille University Hospital , Lille , France"},{"name":"ULR 2694\u00a0\u2013\u00a0METRICS: \u00c9valuation des Technologies de Sant\u00e9 et des Pratiques M\u00e9dicales , University of Lille, Lille University Hospital , Lille , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Cortet","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Metabolism, Hospital Huriez , University Hospital of Lille , Lille , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Jannin","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Metabolism, Hospital Huriez , University Hospital of Lille , Lille , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Do Cao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Metabolism, Hospital Huriez , University Hospital of Lille , Lille , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Douillard","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Metabolism, Hospital Huriez , University Hospital of Lille , Lille , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Soulez","sequence":"additional","affiliation":[{"name":"Laboratory of Biochemistry-Hormonology , Lille University Hospital , Lille , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nassima","family":"Ramdane","sequence":"additional","affiliation":[{"name":"Department of Statistics and Data Management , Lille University Hospital , Lille , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Soudan","sequence":"additional","affiliation":[{"name":"Laboratory of Biochemistry-Hormonology , Lille University Hospital , Lille , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Vantyghem","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Metabolism, Hospital Huriez , University Hospital of Lille , Lille , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Espiard","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Metabolism, Hospital Huriez , University Hospital of Lille , Lille , France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,7,11]]},"reference":[{"key":"2025103114402219891_j_cclm-2025-0133_ref_001","doi-asserted-by":"crossref","unstructured":"Nieman, LK, Biller, BMK, Findling, JW, Newell-Price, J, Savage, MO, Stewart, PM, et al.. The diagnosis of Cushing\u2019s syndrome: an Endocrine Society Clinical Practice Guideline. J\u00a0Clin Endocrinol Metab 2008;93:1526\u201340. https:\/\/doi.org\/10.1210\/jc.2008-0125.","DOI":"10.1210\/jc.2008-0125"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_002","doi-asserted-by":"crossref","unstructured":"Etxabe, J, Vazquez, JA. Morbidity and mortality in Cushing\u2019s disease: an epidemiological approach. Clin Endocrinol 1994;40:479\u201384. https:\/\/doi.org\/10.1111\/j.1365-2265.1994.tb02486.x.","DOI":"10.1111\/j.1365-2265.1994.tb02486.x"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_003","doi-asserted-by":"crossref","unstructured":"Lindholm, J, Juul, S, J\u00f8rgensen, JO, Astrup, J, Bjerre, P, Feldt-Rasmussen, U, et al.. Incidence and late prognosis of cushing\u2019s syndrome: a population-based study. J\u00a0Clin Endocrinol Metab 2001;86:117\u201323. https:\/\/doi.org\/10.1210\/jcem.86.1.7093.","DOI":"10.1210\/jcem.86.1.7093"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_004","doi-asserted-by":"crossref","unstructured":"Raff, H, Carroll, T. Cushing\u2019s syndrome: from physiological principles to diagnosis and clinical care. J\u00a0Physiol 2015;593:493\u2013506. https:\/\/doi.org\/10.1113\/jphysiol.2014.282871.","DOI":"10.1113\/jphysiol.2014.282871"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_005","doi-asserted-by":"crossref","unstructured":"Fenske, M. Urinary free cortisol and cortisone excretion in healthy individuals: influence of water loading. Steroids 2006;71:1014\u20138. https:\/\/doi.org\/10.1016\/j.steroids.2006.08.004.","DOI":"10.1016\/j.steroids.2006.08.004"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_006","doi-asserted-by":"crossref","unstructured":"Chan, KCA, Lit, LCW, Law, ELK, Tai, MHL, Yung, CU, Chan, MHM, et al.. Diminished urinary free cortisol excretion in patients with moderate and severe renal impairment. Clin Chem 2004;50:757\u20139. https:\/\/doi.org\/10.1373\/clinchem.2003.029934.","DOI":"10.1373\/clinchem.2003.029934"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_007","doi-asserted-by":"crossref","unstructured":"Fleseriu, M, Auchus, R, Bancos, I, Ben-Shlomo, A, Bertherat, J, Biermasz, NR, et al.. Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update. Lancet Diabetes Endocrinol 2021;9:847\u201375. https:\/\/doi.org\/10.1016\/s2213-8587(21)00235-7.","DOI":"10.1016\/S2213-8587(21)00235-7"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_008","doi-asserted-by":"crossref","unstructured":"Guaraldi, F, La Selva, R, Sam\u00e0, MT, D\u2019Angelo, V, Gori, D, Fava, P, et al.. Characterization and implications of thyroid dysfunction induced by immune checkpoint inhibitors in real-life clinical practice: a long-term prospective study from a referral institution. J\u00a0Endocrinol Investig 2018;41:549\u201356. https:\/\/doi.org\/10.1007\/s40618-017-0772-1.","DOI":"10.1007\/s40618-017-0772-1"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_009","doi-asserted-by":"crossref","unstructured":"Tabarin, A, Assi\u00e9, G, Barat, P, Bonnet, F, Bonneville, JF, Borson-Chazot, F, et al.. Consensus statement by the French Society of Endocrinology (SFE) and French Society of Pediatric Endocrinology & Diabetology (SFEDP) on diagnosis of Cushing\u2019s syndrome. Ann Endocrinol 2022;83:119\u201341. https:\/\/doi.org\/10.1016\/j.ando.2022.02.001.","DOI":"10.1016\/j.ando.2022.02.001"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_010","doi-asserted-by":"crossref","unstructured":"Raff, H. Update on late-night salivary cortisol for the diagnosis of Cushing\u2019s syndrome: methodological considerations. Endocrine 2013;44:346\u20139. https:\/\/doi.org\/10.1007\/s12020-013-0013-0.","DOI":"10.1007\/s12020-013-0013-0"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_011","doi-asserted-by":"crossref","unstructured":"Goyal, A, Attri, B, Gupta, Y, Kalaivani, M, Jyotsna, VP, Tandon, N. Late-night salivary cortisol cut-offs for diagnosis of Cushing syndrome using second-generation electrochemiluminescence immunoassay kits. Clin Endocrinol 2023;99:43\u201351. https:\/\/doi.org\/10.1111\/cen.14920.","DOI":"10.1111\/cen.14920"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_012","doi-asserted-by":"crossref","unstructured":"Valassi, E, Franz, H, Brue, T, Feelders, RA, Netea-Maier, R, Tsagarakis, S, et al.. Diagnostic tests for Cushing\u2019s syndrome differ from published guidelines: data from ERCUSYN. Eur J Endocrinol 2017;176:613\u201324. https:\/\/doi.org\/10.1530\/eje-16-0967.","DOI":"10.1530\/EJE-16-0967"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_013","doi-asserted-by":"crossref","unstructured":"Galm, BP, Qiao, N, Klibanski, A, Biller, BMK, Tritos, NA. Accuracy of laboratory tests for the diagnosis of cushing syndrome. J\u00a0Clin Endocrinol Metab 2020;105:dgaa105. https:\/\/doi.org\/10.1210\/clinem\/dgaa105.","DOI":"10.1210\/clinem\/dgaa105"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_014","doi-asserted-by":"crossref","unstructured":"DeLong, ER, DeLong, DM, Clarke-Pearson, DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837\u201345. https:\/\/doi.org\/10.2307\/2531595.","DOI":"10.2307\/2531595"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_015","doi-asserted-by":"crossref","unstructured":"Kelsall, A, Newell-Price, J. Cushing\u2019s disease-from Minnie G to key issues in the early 21st century. Lancet Diabetes Endocrinol 2019;7:959\u201364. https:\/\/doi.org\/10.1016\/s2213-8587(19)30343-2.","DOI":"10.1016\/S2213-8587(19)30343-2"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_016","doi-asserted-by":"crossref","unstructured":"Boyar, RM, Witkin, M, Carruth, A, Ramsey, J. Circadian cortisol secretory rhythms in Cushing\u2019s disease. J\u00a0Clin Endocrinol Metab 1979;48:760\u20135. https:\/\/doi.org\/10.1210\/jcem-48-5-760.","DOI":"10.1210\/jcem-48-5-760"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_017","doi-asserted-by":"crossref","unstructured":"Kahn, JP, Rubinow, DR, Davis, CL, Kling, M, Post, RM. Salivary cortisol: a practical method for evaluation of adrenal function. Biol Psychiatry 1988;23:335\u201349. https:\/\/doi.org\/10.1016\/0006-3223(88)90284-3.","DOI":"10.1016\/0006-3223(88)90284-3"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_018","doi-asserted-by":"crossref","unstructured":"Bolufer, P, Gandia, A, Rodriguez, A, Antonio, P. Salivary corticosteroids in the study of adrenal function. Clin Chim Acta 1989;183:217\u201325. https:\/\/doi.org\/10.1016\/0009-8981(89)90337-9.","DOI":"10.1016\/0009-8981(89)90337-9"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_019","doi-asserted-by":"crossref","unstructured":"Halbreich, U, Zumoff, B, Kream, J, Fukushima, DK. The mean 1300\u20131600\u00a0h plasma cortisol concentration as a diagnostic test for hypercortisolism. J\u00a0Clin Endocrinol Metab 1982;54:1262\u20134. https:\/\/doi.org\/10.1210\/jcem-54-6-1262.","DOI":"10.1210\/jcem-54-6-1262"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_020","doi-asserted-by":"crossref","unstructured":"Putignano, P, Toja, P, Dubini, A, Pecori Giraldi, F, Corsello, SM, Cavagnini, F. Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing\u2019s syndrome. J\u00a0Clin Endocrinol Metab 2003;88:4153\u20137. https:\/\/doi.org\/10.1210\/jc.2003-030312.","DOI":"10.1210\/jc.2003-030312"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_021","doi-asserted-by":"crossref","unstructured":"Elias, PCL, Martinez, EZ, Barone, BFC, Mermejo, LM, Castro, M, Moreira, AC. Late-night salivary cortisol has a better performance than urinary free cortisol in the diagnosis of Cushing\u2019s syndrome. J\u00a0Clin Endocrinol Metab 2014;99:2045\u201351. https:\/\/doi.org\/10.1210\/jc.2013-4262.","DOI":"10.1210\/jc.2013-4262"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_022","doi-asserted-by":"crossref","unstructured":"Sharma, ST, Nieman, LK, Feelders, RA. Cushing\u2019s syndrome: epidemiology and developments in disease management. Clin Epidemiol 2015;7:281\u201393. https:\/\/doi.org\/10.2147\/clep.s44336.","DOI":"10.2147\/CLEP.S44336"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_023","doi-asserted-by":"crossref","unstructured":"Hirsch, D, Tsvetov, G, Manisterski, Y, Aviran-Barak, N, Nadler, V, Alboim, S, et al.. Incidence of Cushing\u2019s syndrome in patients with significant hypercortisoluria. Eur J Endocrinol 2017;176:41\u20138. https:\/\/doi.org\/10.1530\/eje-16-0631.","DOI":"10.1530\/EJE-16-0631"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_024","unstructured":"Borsi, L, Mannelli, M, Barbieri, U, Giannotti, P, Serio, M. Measurement of urinary free cortisol by radioimmunoassay and its clinical applications. J\u00a0Nucl Biol Med 1976;20:160\u20134."},{"key":"2025103114402219891_j_cclm-2025-0133_ref_025","unstructured":"de Pedrazzini, ME, Bruno, OD, Gros, EG. Analysis of urinary steroid profiles of women with Cushing\u2019s syndrome by computerised gas chromatography-mass spectrometry. Acta Physiol Lat Am 1983;33:243\u201352."},{"key":"2025103114402219891_j_cclm-2025-0133_ref_026","unstructured":"Itsuji, Y, Tanaka, K, Tanabe, T, Takahashi, H. Evaluation of urinary excretion of free-cortisol in patients with abnormal pituitary-adrenal axes. Rinsho Byori 1997;45:265\u201370."},{"key":"2025103114402219891_j_cclm-2025-0133_ref_027","unstructured":"Nishikawa, T, Tamura, Y, Kumagaya, A. Studies on the determination of cortisol by Gamma Coat kit (author\u2019s transl). Horumon Rinsho 1980;28:471\u20136."},{"key":"2025103114402219891_j_cclm-2025-0133_ref_028","doi-asserted-by":"crossref","unstructured":"G\u00fcnes, M, Celik, O, Kadioglu, P. Reliability of the diagnostic tests for Cushing\u2019s syndrome performed in a tertiary referral center. Pituitary 2013;16:139\u201345. https:\/\/doi.org\/10.1007\/s11102-012-0387-7.","DOI":"10.1007\/s11102-012-0387-7"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_029","doi-asserted-by":"crossref","unstructured":"Ng, CM, Lam, TK, Au Yeung, YC, Choi, CH, Iu, YP, Shek, CC, et al.. Clinical utility of late-night and post-overnight dexamethasone suppression salivary cortisone for the investigation of Cushing\u2019s syndrome. Hong Kong Med J 2017;23:570\u20138. https:\/\/doi.org\/10.12809\/hkmj176240.","DOI":"10.12809\/hkmj176240"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_030","doi-asserted-by":"crossref","unstructured":"Tamada, D, Kitamura, T, Takahara, M, Tanaka, T, Takeda, M, Otsuki, M, et al.. TSH ratio as a novel diagnostic method for Cushing\u2019s syndrome. Endocr J 2018;65:841\u20138. https:\/\/doi.org\/10.1507\/endocrj.ej18-0101.","DOI":"10.1507\/endocrj.EJ18-0101"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_031","doi-asserted-by":"crossref","unstructured":"Pecori Giraldi, F, Pivonello, R, Ambrogio, AG, De Martino, MC, De Martin, M, Scacchi, M, et al.. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing\u2019s syndrome from pseudo-Cushing\u2019s states. Clin Endocrinol 2007;66:251\u20137. https:\/\/doi.org\/10.1111\/j.1365-2265.2006.02717.x.","DOI":"10.1111\/j.1365-2265.2006.02717.x"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_032","doi-asserted-by":"crossref","unstructured":"Reimondo, G, Bovio, S, Allasino, B, De Francia, S, Zaggia, B, Micossi, I, et al.. The combined low-dose dexamethasone suppression corticotropin-releasing hormone test as a tool to rule out Cushing\u2019s syndrome. Eur J Endocrinol 2008;159:569\u201376. https:\/\/doi.org\/10.1530\/eje-08-0402.","DOI":"10.1530\/EJE-08-0402"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_033","doi-asserted-by":"crossref","unstructured":"Fassnacht, M, Tsagarakis, S, Terzolo, M, Tabarin, A, Sahdev, A, Newell-Price, J, et al.. European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 2023;189:G1\u201342. https:\/\/doi.org\/10.1093\/ejendo\/lvad066.","DOI":"10.1093\/ejendo\/lvad066"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_034","doi-asserted-by":"crossref","unstructured":"Ceccato, F, Marcelli, G, Martino, M, Concettoni, C, Brugia, M, Trementino, L, et al.. The diagnostic accuracy of increased late night salivary cortisol for Cushing\u2019s syndrome: a real-life prospective study. J\u00a0Endocrinol Investig 2019;42:327\u201335. https:\/\/doi.org\/10.1007\/s40618-018-0921-1.","DOI":"10.1007\/s40618-018-0921-1"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_035","doi-asserted-by":"crossref","unstructured":"Ueland, G\u00c5, Methlie, P, Kellmann, R, Bj\u00f8rgaas, M, \u00c5svold, BO, Thorstensen, K, et al.. Simultaneous assay of cortisol and dexamethasone improved diagnostic accuracy of the dexamethasone suppression test. Eur J Endocrinol 2017;176:705\u201313. https:\/\/doi.org\/10.1530\/eje-17-0078.","DOI":"10.1530\/EJE-17-0078"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_036","doi-asserted-by":"crossref","unstructured":"Nunes, ML, Vattaut, S, Corcuff, JB, Rault, A, Loiseau, H, Gatta, B, et al.. Late-night salivary cortisol for diagnosis of overt and subclinical Cushing\u2019s syndrome in hospitalized and ambulatory patients. J\u00a0Clin Endocrinol Metab 2009;94:456\u201362. https:\/\/doi.org\/10.1210\/jc.2008-1542.","DOI":"10.1210\/jc.2008-1542"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_037","doi-asserted-by":"crossref","unstructured":"Deutschbein, T, Unger, N, Hinrichs, J, Walz, MK, Mann, K, Petersenn, S. Late-night and low-dose dexamethasone-suppressed cortisol in saliva and serum for the diagnosis of cortisol-secreting adrenal adenomas. Eur J Endocrinol 2009;161:747\u201353. https:\/\/doi.org\/10.1530\/eje-09-0517.","DOI":"10.1530\/EJE-09-0517"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_038","doi-asserted-by":"crossref","unstructured":"Araya, AV, Romero, C, Lemp, M. Combined dexamethasone and desmopressin test in the differential diagnosis of ACTH-dependent Cushing\u2019s syndrome and pseudo-cushing\u2019s states. Pituitary 2017;20:602\u20133. https:\/\/doi.org\/10.1007\/s11102-017-0824-8.","DOI":"10.1007\/s11102-017-0824-8"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_039","doi-asserted-by":"crossref","unstructured":"Arnaldi, G, Tirabassi, G, Papa, R, Furlani, G, Trementino, L, Cardinaletti, M, et al.. Human corticotropin releasing hormone test performance in the differential diagnosis between Cushing\u2019s disease and pseudo-Cushing state is enhanced by combined ACTH and cortisol analysis. Eur J Endocrinol 2009;160:891\u20138. https:\/\/doi.org\/10.1530\/eje-09-0125.","DOI":"10.1530\/EJE-09-0125"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_040","doi-asserted-by":"crossref","unstructured":"Tirabassi, G, Faloia, E, Papa, R, Furlani, G, Boscaro, M, Arnaldi, G. Use of the desmopressin test in the differential diagnosis of pseudo-Cushing state from Cushing\u2019s disease. J\u00a0Clin Endocrinol Metab 2010;95:1115\u201322. https:\/\/doi.org\/10.1210\/jc.2009-1146.","DOI":"10.1210\/jc.2009-1146"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_041","doi-asserted-by":"crossref","unstructured":"Scaroni, C, Mondin, A, Ceccato, F. How to rule out non-neoplastic hypercortisolemia (previously known as pseudo-cushing). Pituitary 2022;25:701\u20134. https:\/\/doi.org\/10.1007\/s11102-022-01222-2.","DOI":"10.1007\/s11102-022-01222-2"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_042","doi-asserted-by":"crossref","unstructured":"Danet-Lamasou, M, Asselineau, J, Perez, P, Vivot, A, Nunes, ML, Loiseau, H, et al.. Accuracy of repeated measurements of late-night salivary cortisol to screen for early-stage recurrence of Cushing\u2019s disease following pituitary surgery. Clin Endocrinol 2015;82:260\u20136. https:\/\/doi.org\/10.1111\/cen.12534.","DOI":"10.1111\/cen.12534"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_043","doi-asserted-by":"crossref","unstructured":"Newell-Price, J, Pivonello, R, Tabarin, A, Fleseriu, M, Witek, P, Gadelha, MR, et al.. Use of late-night salivary cortisol to monitor response to medical treatment in Cushing\u2019s disease. Eur J Endocrinol 2020;182:207\u201317. https:\/\/doi.org\/10.1530\/eje-19-0695.","DOI":"10.1530\/EJE-19-0695"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_044","doi-asserted-by":"crossref","unstructured":"Raff, H, Raff, JL, Findling, JW. Late-night salivary cortisol as a screening test for Cushing\u2019s syndrome. J\u00a0Clin Endocrinol Metab 1998;83:2681\u20136. https:\/\/doi.org\/10.1210\/jcem.83.8.4936.","DOI":"10.1210\/jc.83.8.2681"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_045","doi-asserted-by":"crossref","unstructured":"Carrozza, C, Corsello, SM, Paragliola, RM, Ingraudo, F, Palumbo, S, Locantore, P, et al.. Clinical accuracy of midnight salivary cortisol measured by automated electrochemiluminescence immunoassay method in Cushing\u2019s syndrome. Ann Clin Biochem 2010;47:228\u201332. https:\/\/doi.org\/10.1258\/acb.2010.010020.","DOI":"10.1258\/acb.2010.010020"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_046","doi-asserted-by":"crossref","unstructured":"Ceccato, F, Barbot, M, Zilio, M, Frigo, AC, Albiger, N, Camozzi, V, et al.. Screening tests for Cushing\u2019s syndrome: urinary free cortisol role measured by LC-MS\/MS. J\u00a0Clin Endocrinol Metab 2015;100:3856\u201361. https:\/\/doi.org\/10.1210\/jc.2015-2507.","DOI":"10.1210\/jc.2015-2507"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_047","doi-asserted-by":"crossref","unstructured":"Deutschbein, T, Broecker-Preuss, M, Hartmann, MF, Althoff, R, Wudy, SA, Mann, K, et al.. Measurement of urinary free cortisol by current immunoassays: need for sex-dependent reference ranges to define hypercortisolism. Horm Metab Res 2011;43:714\u20139. https:\/\/doi.org\/10.1055\/s-0031-1286297.","DOI":"10.1055\/s-0031-1286297"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_048","doi-asserted-by":"crossref","unstructured":"Petersenn, S, Newell-Price, J, Findling, JW, Gu, F, Maldonado, M, Sen, K, et al.. High variability in baseline urinary free cortisol values in patients with Cushing\u2019s disease. Clin Endocrinol 2014;80:261\u20139. https:\/\/doi.org\/10.1111\/cen.12259.","DOI":"10.1111\/cen.12259"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_049","doi-asserted-by":"crossref","unstructured":"Carrasco, CA, Garc\u00eda, M, Goycoolea, M, Cerda, J, Bertherat, J, Padilla, O, et al.. Reproducibility and performance of one or two samples of salivary cortisol in the diagnosis of Cushing\u2019s syndrome using an automated immunoassay system. Endocrine 2012;41:487\u201393. https:\/\/doi.org\/10.1007\/s12020-012-9597-z.","DOI":"10.1007\/s12020-012-9597-z"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_050","doi-asserted-by":"crossref","unstructured":"Pecori Giraldi, F, Ambrogio, AG. Variability in laboratory parameters used for management of Cushing\u2019s syndrome. Endocrine 2015;50:580\u20139. https:\/\/doi.org\/10.1007\/s12020-015-0676-9.","DOI":"10.1007\/s12020-015-0676-9"},{"key":"2025103114402219891_j_cclm-2025-0133_ref_051","unstructured":"Pikkarainen, L, Alfthan, H, Markkanen, H, Sane, T. Midnight serum cortisol: comparison of healthy volunteers and hospitalized patients with Cushing\u2019s syndrome. Scand J Clin Lab Invest 2002;62:357\u201360."},{"key":"2025103114402219891_j_cclm-2025-0133_ref_052","doi-asserted-by":"crossref","unstructured":"Maes, M, Mommen, K, Hendrickx, D, Peeters, D, D\u2019Hondt, P, Ranjan, R, et al.. Components of biological variation, including seasonality, in blood concentrations of TSH, TT3, FT4, PRL, cortisol and testosterone in healthy volunteers. Clin Endocrinol 1997;46:587\u201398. https:\/\/doi.org\/10.1046\/j.1365-2265.1997.1881002.x.","DOI":"10.1046\/j.1365-2265.1997.1881002.x"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2025-0133\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2025-0133\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:40:58Z","timestamp":1761921658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2025-0133\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":52,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,6,26]]},"published-print":{"date-parts":[[2025,10,27]]}},"alternative-id":["10.1515\/cclm-2025-0133"],"URL":"https:\/\/doi.org\/10.1515\/cclm-2025-0133","relation":{},"ISSN":["1434-6621","1437-4331"],"issn-type":[{"value":"1434-6621","type":"print"},{"value":"1437-4331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,11]]}}}